Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.06806446 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.06806446 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.98138738 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.98138738 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.06485199 |
6 | sulfur amino acid catabolic process (GO:0000098) | 4.87826190 |
7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.77728451 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.65312988 |
9 | cysteine metabolic process (GO:0006534) | 4.58987717 |
10 | glyoxylate metabolic process (GO:0046487) | 4.58588339 |
11 | bile acid biosynthetic process (GO:0006699) | 4.57553139 |
12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.40570009 |
13 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.35759423 |
14 | kynurenine metabolic process (GO:0070189) | 4.31729066 |
15 | tryptophan catabolic process (GO:0006569) | 4.26353054 |
16 | indole-containing compound catabolic process (GO:0042436) | 4.26353054 |
17 | indolalkylamine catabolic process (GO:0046218) | 4.26353054 |
18 | lysine metabolic process (GO:0006553) | 4.24485564 |
19 | lysine catabolic process (GO:0006554) | 4.24485564 |
20 | GDP-mannose metabolic process (GO:0019673) | 4.20192979 |
21 | protein carboxylation (GO:0018214) | 4.19425215 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.19425215 |
23 | negative regulation of fibrinolysis (GO:0051918) | 4.13249073 |
24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.08755356 |
25 | protein maturation by protein folding (GO:0022417) | 4.05492599 |
26 | coenzyme catabolic process (GO:0009109) | 4.02379156 |
27 | amino-acid betaine metabolic process (GO:0006577) | 3.99680150 |
28 | tryptophan metabolic process (GO:0006568) | 3.98013783 |
29 | urea cycle (GO:0000050) | 3.89216546 |
30 | urea metabolic process (GO:0019627) | 3.89216546 |
31 | serine family amino acid catabolic process (GO:0009071) | 3.88623465 |
32 | regulation of protein activation cascade (GO:2000257) | 3.88197808 |
33 | aromatic amino acid family metabolic process (GO:0009072) | 3.84135007 |
34 | cellular ketone body metabolic process (GO:0046950) | 3.82352719 |
35 | bile acid metabolic process (GO:0008206) | 3.79900022 |
36 | regulation of fibrinolysis (GO:0051917) | 3.77670122 |
37 | cellular modified amino acid catabolic process (GO:0042219) | 3.74225798 |
38 | regulation of complement activation (GO:0030449) | 3.71757919 |
39 | regulation of cholesterol esterification (GO:0010872) | 3.70284160 |
40 | complement activation, alternative pathway (GO:0006957) | 3.67255085 |
41 | alpha-amino acid catabolic process (GO:1901606) | 3.62920301 |
42 | plasma lipoprotein particle clearance (GO:0034381) | 3.62877902 |
43 | cofactor catabolic process (GO:0051187) | 3.61769640 |
44 | reverse cholesterol transport (GO:0043691) | 3.61717267 |
45 | homocysteine metabolic process (GO:0050667) | 3.61486515 |
46 | nitrogen cycle metabolic process (GO:0071941) | 3.60560232 |
47 | tyrosine metabolic process (GO:0006570) | 3.57615196 |
48 | aspartate family amino acid catabolic process (GO:0009068) | 3.55804499 |
49 | cellular amino acid catabolic process (GO:0009063) | 3.52496670 |
50 | aldehyde catabolic process (GO:0046185) | 3.50877752 |
51 | regulation of cholesterol homeostasis (GO:2000188) | 3.49199900 |
52 | short-chain fatty acid metabolic process (GO:0046459) | 3.49161490 |
53 | ethanol oxidation (GO:0006069) | 3.48277931 |
54 | regulation of triglyceride catabolic process (GO:0010896) | 3.46595605 |
55 | acetyl-CoA metabolic process (GO:0006084) | 3.45358430 |
56 | fatty acid beta-oxidation (GO:0006635) | 3.40395845 |
57 | pinocytosis (GO:0006907) | 3.40075453 |
58 | glutamate metabolic process (GO:0006536) | 3.39352547 |
59 | serine family amino acid metabolic process (GO:0009069) | 3.37675038 |
60 | ketone body metabolic process (GO:1902224) | 3.36901781 |
61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.36148027 |
62 | protein-lipid complex remodeling (GO:0034368) | 3.36148027 |
63 | macromolecular complex remodeling (GO:0034367) | 3.36148027 |
64 | fatty acid oxidation (GO:0019395) | 3.36129495 |
65 | negative regulation of sterol transport (GO:0032372) | 3.32406551 |
66 | negative regulation of cholesterol transport (GO:0032375) | 3.32406551 |
67 | lipid oxidation (GO:0034440) | 3.31633740 |
68 | fatty acid catabolic process (GO:0009062) | 3.30988668 |
69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.30842173 |
70 | serine family amino acid biosynthetic process (GO:0009070) | 3.29793171 |
71 | organic acid catabolic process (GO:0016054) | 3.26777038 |
72 | carboxylic acid catabolic process (GO:0046395) | 3.26777038 |
73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26328971 |
74 | triglyceride homeostasis (GO:0070328) | 3.25284848 |
75 | acylglycerol homeostasis (GO:0055090) | 3.25284848 |
76 | COPI coating of Golgi vesicle (GO:0048205) | 3.24897277 |
77 | Golgi transport vesicle coating (GO:0048200) | 3.24897277 |
78 | monocarboxylic acid catabolic process (GO:0072329) | 3.24369913 |
79 | phospholipid efflux (GO:0033700) | 3.23205082 |
80 | very long-chain fatty acid metabolic process (GO:0000038) | 3.22610850 |
81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22263350 |
82 | fibrinolysis (GO:0042730) | 3.20711873 |
83 | neutrophil activation involved in immune response (GO:0002283) | 3.17234844 |
84 | 2-oxoglutarate metabolic process (GO:0006103) | 3.15922428 |
85 | cellular glucuronidation (GO:0052695) | 3.15677402 |
86 | carnitine metabolic process (GO:0009437) | 3.14223831 |
87 | cholesterol efflux (GO:0033344) | 3.12377977 |
88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11473027 |
89 | response to mercury ion (GO:0046689) | 3.11250964 |
90 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.10455855 |
91 | heme transport (GO:0015886) | 3.09663099 |
92 | regulation of cholesterol metabolic process (GO:0090181) | 3.09588854 |
93 | glycine metabolic process (GO:0006544) | 3.09292166 |
94 | drug catabolic process (GO:0042737) | 3.06593543 |
95 | glucuronate metabolic process (GO:0019585) | 3.06368794 |
96 | uronic acid metabolic process (GO:0006063) | 3.06368794 |
97 | benzene-containing compound metabolic process (GO:0042537) | 3.04443803 |
98 | drug transmembrane transport (GO:0006855) | 3.03383366 |
99 | urate metabolic process (GO:0046415) | 3.01243749 |
100 | valine metabolic process (GO:0006573) | 2.98900871 |
101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.97603066 |
102 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.97603066 |
103 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.97232451 |
104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.96449912 |
105 | arginine metabolic process (GO:0006525) | 2.96294308 |
106 | amino sugar catabolic process (GO:0046348) | 2.95081463 |
107 | proline biosynthetic process (GO:0006561) | 2.94364801 |
108 | branched-chain amino acid catabolic process (GO:0009083) | 2.93948490 |
109 | biotin metabolic process (GO:0006768) | 2.89914270 |
110 | bile acid and bile salt transport (GO:0015721) | 2.89380602 |
111 | acyl-CoA metabolic process (GO:0006637) | 2.89368660 |
112 | thioester metabolic process (GO:0035383) | 2.89368660 |
113 | indolalkylamine metabolic process (GO:0006586) | 2.88952011 |
114 | positive regulation of lipid catabolic process (GO:0050996) | 2.87516828 |
115 | negative regulation of protein activation cascade (GO:2000258) | 2.87493808 |
116 | response to interferon-beta (GO:0035456) | 2.81561063 |
117 | immunoglobulin mediated immune response (GO:0016064) | 2.74897344 |
118 | NIK/NF-kappaB signaling (GO:0038061) | 2.71761088 |
119 | cellular response to interferon-beta (GO:0035458) | 2.69766641 |
120 | autophagic vacuole fusion (GO:0000046) | 2.68909905 |
121 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67474913 |
122 | mannose metabolic process (GO:0006013) | 2.61964489 |
123 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.58986896 |
124 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.56518427 |
125 | response to peptidoglycan (GO:0032494) | 2.55481965 |
126 | mature B cell differentiation involved in immune response (GO:0002313) | 2.54871862 |
127 | lipoxygenase pathway (GO:0019372) | 2.52603698 |
128 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.47443136 |
129 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.46348015 |
130 | NADH metabolic process (GO:0006734) | 2.43698065 |
131 | regulation of superoxide anion generation (GO:0032928) | 2.39314759 |
132 | detection of bacterium (GO:0016045) | 2.38819633 |
133 | UV protection (GO:0009650) | 2.37516158 |
134 | regulation of RIG-I signaling pathway (GO:0039535) | 2.37451713 |
135 | regulation of metalloenzyme activity (GO:0048552) | 2.36494033 |
136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.35651925 |
137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.33547254 |
138 | amyloid precursor protein catabolic process (GO:0042987) | 2.32991910 |
139 | glycosphingolipid catabolic process (GO:0046479) | 2.30563396 |
140 | barbed-end actin filament capping (GO:0051016) | 2.30527679 |
141 | heme biosynthetic process (GO:0006783) | 2.30376973 |
142 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.30096953 |
143 | metallo-sulfur cluster assembly (GO:0031163) | 2.29350093 |
144 | iron-sulfur cluster assembly (GO:0016226) | 2.29350093 |
145 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.28901519 |
146 | organelle membrane fusion (GO:0090174) | 2.28088812 |
147 | actin nucleation (GO:0045010) | 2.27565426 |
148 | detection of other organism (GO:0098543) | 2.26876456 |
149 | negative regulation of innate immune response (GO:0045824) | 2.26687330 |
150 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.26347141 |
151 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.26223033 |
152 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.24741613 |
153 | heme metabolic process (GO:0042168) | 2.23990595 |
154 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.22171897 |
155 | regulation of chemokine biosynthetic process (GO:0045073) | 2.21638731 |
156 | regulation of mitochondrial membrane potential (GO:0051881) | 2.19801088 |
157 | positive regulation of B cell differentiation (GO:0045579) | 2.19177048 |
158 | xenobiotic catabolic process (GO:0042178) | 2.19104071 |
159 | macrophage activation involved in immune response (GO:0002281) | 2.17132451 |
160 | positive regulation by symbiont of host defense response (GO:0052509) | 2.16371936 |
161 | modulation by symbiont of host defense response (GO:0052031) | 2.16371936 |
162 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.16371936 |
163 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.16371936 |
164 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.16371936 |
165 | modulation by symbiont of host immune response (GO:0052553) | 2.16371936 |
166 | proline metabolic process (GO:0006560) | 2.14552975 |
167 | hyaluronan catabolic process (GO:0030214) | 2.14085299 |
168 | cellular response to type I interferon (GO:0071357) | 2.13716912 |
169 | type I interferon signaling pathway (GO:0060337) | 2.13716912 |
170 | pyrimidine-containing compound salvage (GO:0008655) | 2.13093018 |
171 | pyrimidine nucleoside salvage (GO:0043097) | 2.13093018 |
172 | myeloid cell activation involved in immune response (GO:0002275) | 2.13092896 |
173 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.12694714 |
174 | glycolipid catabolic process (GO:0019377) | 2.12546561 |
175 | myeloid dendritic cell differentiation (GO:0043011) | 2.11732400 |
176 | fibril organization (GO:0097435) | 2.11033599 |
177 | response to type I interferon (GO:0034340) | 2.08853148 |
178 | pentose metabolic process (GO:0019321) | 2.08751618 |
179 | response to thyroid hormone (GO:0097066) | 2.08685998 |
180 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.08206143 |
181 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.07385376 |
182 | type B pancreatic cell proliferation (GO:0044342) | 2.07302540 |
183 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.06595681 |
184 | regulation of defense response to virus by virus (GO:0050690) | 2.06519635 |
185 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.06004729 |
186 | negative regulation of cell killing (GO:0031342) | 2.06004729 |
187 | myeloid dendritic cell activation (GO:0001773) | 2.05668525 |
188 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.05659100 |
189 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.04525770 |
190 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.04101165 |
191 | cyclooxygenase pathway (GO:0019371) | 2.03605392 |
192 | leukocyte aggregation (GO:0070486) | 2.02999697 |
193 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.01521309 |
194 | glucose catabolic process (GO:0006007) | 2.00954575 |
195 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.00946239 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.14798633 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.97707614 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.38425610 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.18223442 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.44388599 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.88686603 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.58734290 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29574406 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.28228180 |
10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.74105943 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.60280109 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.54179135 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43043931 |
14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.40355670 |
15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.38921755 |
16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.36343660 |
17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.34512729 |
18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00785491 |
19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.99815831 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96684910 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95126761 |
22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94883854 |
23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82985184 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82650658 |
25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82008299 |
26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79610038 |
27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79250893 |
28 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.78244475 |
29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76473629 |
30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74436215 |
31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72494466 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.67490910 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65783279 |
34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62951089 |
35 | * MAF_26560356_Chip-Seq_TH1_Human | 1.59784569 |
36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59302694 |
37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56111587 |
38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53090186 |
39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52805748 |
40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50176763 |
41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48888877 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48593628 |
43 | MYC_22102868_ChIP-Seq_BL_Human | 1.48179176 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46799769 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44678421 |
46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44255765 |
47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43910535 |
48 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41748411 |
49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.41499766 |
50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40877038 |
51 | MAF_26560356_Chip-Seq_TH2_Human | 1.40041877 |
52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39579340 |
53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39334861 |
54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37998239 |
55 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.37741691 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37221723 |
57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35767884 |
58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35764047 |
59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33458257 |
60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30532706 |
61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30460346 |
62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30155472 |
63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30144308 |
64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29992672 |
65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27293648 |
66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26648065 |
67 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26621308 |
68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24907755 |
69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23600959 |
70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22866051 |
71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22775076 |
72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22644667 |
73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22188835 |
74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22062565 |
75 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21625708 |
76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21182048 |
77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21177072 |
78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19605036 |
79 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.18185905 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18043778 |
81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17176462 |
82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16996400 |
83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16182919 |
84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16129344 |
85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15611415 |
86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14915896 |
87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12999878 |
88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.12953267 |
89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11826733 |
90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11743981 |
91 | MYB_26560356_Chip-Seq_TH2_Human | 1.11493455 |
92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09874191 |
93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09598769 |
94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09354431 |
95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08453166 |
96 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07964938 |
97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07944222 |
98 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06950271 |
99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06575744 |
100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05153314 |
101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04948081 |
102 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04627774 |
103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03821573 |
104 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02400794 |
105 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02107953 |
106 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02012177 |
107 | MYB_26560356_Chip-Seq_TH1_Human | 1.01628385 |
108 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01610856 |
109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01600671 |
110 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00969376 |
111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98571765 |
112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98169778 |
113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98162765 |
114 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97680329 |
115 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97269116 |
116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95417611 |
117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93238215 |
118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93169913 |
119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91837745 |
120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91398107 |
121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90342696 |
122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90099587 |
123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89284051 |
124 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.88878479 |
125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88373895 |
126 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87457914 |
127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87415290 |
128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86718109 |
129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.84265646 |
130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83495666 |
131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81971384 |
132 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.81954498 |
133 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81813946 |
134 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81635398 |
135 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.81448944 |
136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81402973 |
137 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80838673 |
138 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78702118 |
139 | * P68_20966046_ChIP-Seq_HELA_Human | 0.77955488 |
140 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.77310870 |
141 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76778098 |
142 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.76581736 |
143 | SA1_27219007_Chip-Seq_Bcells_Human | 0.76510276 |
144 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74993704 |
145 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74975981 |
146 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.73187659 |
147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72968609 |
148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72968609 |
149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72071619 |
150 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69602477 |
151 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.69397583 |
152 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69273240 |
153 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.69090299 |
154 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68298687 |
155 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.67618137 |
156 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.67391422 |
157 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.67376815 |
158 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.66760378 |
159 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.66623395 |
160 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.66289521 |
161 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.66139077 |
162 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.65960611 |
163 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.65816005 |
164 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.65628904 |
165 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65616926 |
166 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.65554470 |
167 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.65181627 |
168 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.64313605 |
169 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63300926 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.35392732 |
2 | MP0005360_urolithiasis | 5.99420279 |
3 | MP0005365_abnormal_bile_salt | 4.78329433 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.48915570 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.29288137 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.07824371 |
7 | MP0009840_abnormal_foam_cell | 3.93922013 |
8 | MP0003195_calcinosis | 3.04656724 |
9 | MP0010329_abnormal_lipoprotein_level | 2.93809385 |
10 | MP0003436_decreased_susceptibility_to | 2.91335790 |
11 | MP0005332_abnormal_amino_acid | 2.89035053 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.61243361 |
13 | MP0003252_abnormal_bile_duct | 2.61021339 |
14 | MP0005083_abnormal_biliary_tract | 2.57081528 |
15 | MP0003329_amyloid_beta_deposits | 2.42269362 |
16 | MP0009333_abnormal_splenocyte_physiolog | 2.40518282 |
17 | MP0001835_abnormal_antigen_presentation | 2.40418547 |
18 | MP0005464_abnormal_platelet_physiology | 2.29650253 |
19 | MP0004019_abnormal_vitamin_homeostasis | 2.24580322 |
20 | MP0005671_abnormal_response_to | 2.24425481 |
21 | MP0002419_abnormal_innate_immunity | 2.16330996 |
22 | MP0009785_altered_susceptibility_to | 2.14309424 |
23 | MP0005025_abnormal_response_to | 2.13955209 |
24 | MP0003705_abnormal_hypodermis_morpholog | 2.12936853 |
25 | MP0008438_abnormal_cutaneous_collagen | 2.10534544 |
26 | MP0002148_abnormal_hypersensitivity_rea | 2.08398747 |
27 | MP0000604_amyloidosis | 2.06832403 |
28 | MP0005000_abnormal_immune_tolerance | 2.02327341 |
29 | MP0002118_abnormal_lipid_homeostasis | 1.98233429 |
30 | MP0000685_abnormal_immune_system | 1.97139644 |
31 | MP0005058_abnormal_lysosome_morphology | 1.96843707 |
32 | MP0001666_abnormal_nutrient_absorption | 1.90307432 |
33 | MP0003763_abnormal_thymus_physiology | 1.80350432 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.76446111 |
35 | MP0003011_delayed_dark_adaptation | 1.76219787 |
36 | MP0000609_abnormal_liver_physiology | 1.72866884 |
37 | MP0003724_increased_susceptibility_to | 1.72675734 |
38 | MP0002723_abnormal_immune_serum | 1.70195408 |
39 | MP0001800_abnormal_humoral_immune | 1.68671609 |
40 | MP0002452_abnormal_antigen_presenting | 1.68589109 |
41 | MP0005275_abnormal_skin_tensile | 1.66138724 |
42 | MP0003186_abnormal_redox_activity | 1.66038876 |
43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63283934 |
44 | MP0000858_altered_metastatic_potential | 1.62916184 |
45 | MP0002420_abnormal_adaptive_immunity | 1.62715441 |
46 | MP0001819_abnormal_immune_cell | 1.61433310 |
47 | MP0005451_abnormal_body_composition | 1.61260251 |
48 | MP0003303_peritoneal_inflammation | 1.60924029 |
49 | MP0009643_abnormal_urine_homeostasis | 1.60728190 |
50 | MP0001790_abnormal_immune_system | 1.59887955 |
51 | MP0005387_immune_system_phenotype | 1.59887955 |
52 | MP0000015_abnormal_ear_pigmentation | 1.57088104 |
53 | MP0001845_abnormal_inflammatory_respons | 1.50887028 |
54 | MP0001873_stomach_inflammation | 1.48433021 |
55 | MP0010155_abnormal_intestine_physiology | 1.47916861 |
56 | MP0002132_abnormal_respiratory_system | 1.43076580 |
57 | MP0001853_heart_inflammation | 1.39222329 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.32362240 |
59 | MP0002405_respiratory_system_inflammati | 1.29685069 |
60 | MP0004947_skin_inflammation | 1.29633089 |
61 | MP0001542_abnormal_bone_strength | 1.24576349 |
62 | MP0002138_abnormal_hepatobiliary_system | 1.23226810 |
63 | MP0001756_abnormal_urination | 1.23085599 |
64 | MP0003300_gastrointestinal_ulcer | 1.22670846 |
65 | MP0008004_abnormal_stomach_pH | 1.19029715 |
66 | MP0001764_abnormal_homeostasis | 1.15163396 |
67 | MP0000716_abnormal_immune_system | 1.15155975 |
68 | MP0004858_abnormal_nervous_system | 1.14618956 |
69 | MP0001545_abnormal_hematopoietic_system | 1.13965629 |
70 | MP0005397_hematopoietic_system_phenotyp | 1.13965629 |
71 | MP0003656_abnormal_erythrocyte_physiolo | 1.13611695 |
72 | MP0005670_abnormal_white_adipose | 1.12370321 |
73 | MP0003183_abnormal_peptide_metabolism | 1.12210266 |
74 | MP0002796_impaired_skin_barrier | 1.12087675 |
75 | MP0006036_abnormal_mitochondrial_physio | 1.11726365 |
76 | MP0005636_abnormal_mineral_homeostasis | 1.11531660 |
77 | MP0005310_abnormal_salivary_gland | 1.08125610 |
78 | MP0002398_abnormal_bone_marrow | 1.06205537 |
79 | MP0003828_pulmonary_edema | 1.05520069 |
80 | MP0003866_abnormal_defecation | 1.05100760 |
81 | MP0009278_abnormal_bone_marrow | 1.04917555 |
82 | MP0002429_abnormal_blood_cell | 1.03075065 |
83 | MP0002722_abnormal_immune_system | 1.02372064 |
84 | MP0000689_abnormal_spleen_morphology | 1.02135751 |
85 | MP0002998_abnormal_bone_remodeling | 0.98867318 |
86 | MP0002295_abnormal_pulmonary_circulatio | 0.98303936 |
87 | MP0001661_extended_life_span | 0.97711286 |
88 | MP0004130_abnormal_muscle_cell | 0.97036778 |
89 | MP0004381_abnormal_hair_follicle | 0.95075929 |
90 | MP0002254_reproductive_system_inflammat | 0.94725504 |
91 | MP0004510_myositis | 0.93785199 |
92 | MP0004043_abnormal_pH_regulation | 0.92168176 |
93 | MP0003690_abnormal_glial_cell | 0.91837415 |
94 | MP0001958_emphysema | 0.91085524 |
95 | MP0000598_abnormal_liver_morphology | 0.90885934 |
96 | MP0005075_abnormal_melanosome_morpholog | 0.90874299 |
97 | MP0009764_decreased_sensitivity_to | 0.89924859 |
98 | MP0005330_cardiomyopathy | 0.85590577 |
99 | MP0002876_abnormal_thyroid_physiology | 0.84218908 |
100 | MP0003448_altered_tumor_morphology | 0.84192956 |
101 | MP0005084_abnormal_gallbladder_morpholo | 0.82329726 |
102 | MP0002933_joint_inflammation | 0.81916532 |
103 | MP0004185_abnormal_adipocyte_glucose | 0.81333007 |
104 | MP0003075_altered_response_to | 0.80676084 |
105 | MP0008260_abnormal_autophagy | 0.80424497 |
106 | MP0005408_hypopigmentation | 0.80372436 |
107 | MP0000681_abnormal_thyroid_gland | 0.80090352 |
108 | MP0003279_aneurysm | 0.79908303 |
109 | MP0002877_abnormal_melanocyte_morpholog | 0.77491887 |
110 | MP0009642_abnormal_blood_homeostasis | 0.77085423 |
111 | MP0008469_abnormal_protein_level | 0.74542703 |
112 | MP0005390_skeleton_phenotype | 0.74250336 |
113 | MP0006035_abnormal_mitochondrial_morpho | 0.74143644 |
114 | MP0000249_abnormal_blood_vessel | 0.73963003 |
115 | MP0003868_abnormal_feces_composition | 0.73911434 |
116 | MP0005535_abnormal_body_temperature | 0.73903415 |
117 | MP0002136_abnormal_kidney_physiology | 0.73574919 |
118 | MP0002166_altered_tumor_susceptibility | 0.73559258 |
119 | MP0002837_dystrophic_cardiac_calcinosis | 0.73049237 |
120 | MP0003795_abnormal_bone_structure | 0.72567133 |
121 | MP0005376_homeostasis/metabolism_phenot | 0.70836143 |
122 | MP0005595_abnormal_vascular_smooth | 0.70653706 |
123 | MP0002078_abnormal_glucose_homeostasis | 0.69473019 |
124 | MP0002090_abnormal_vision | 0.68773079 |
125 | MP0005647_abnormal_sex_gland | 0.67855986 |
126 | MP0009763_increased_sensitivity_to | 0.66139137 |
127 | MP0000747_muscle_weakness | 0.65569550 |
128 | MP0003638_abnormal_response/metabolism_ | 0.65140054 |
129 | MP0001984_abnormal_olfaction | 0.64078882 |
130 | MP0001765_abnormal_ion_homeostasis | 0.63735739 |
131 | MP0005023_abnormal_wound_healing | 0.63305582 |
132 | MP0000230_abnormal_systemic_arterial | 0.62781165 |
133 | MP0000013_abnormal_adipose_tissue | 0.62453594 |
134 | MP0002971_abnormal_brown_adipose | 0.62307940 |
135 | MP0002168_other_aberrant_phenotype | 0.62231616 |
136 | MP0005164_abnormal_response_to | 0.62081207 |
137 | MP0008874_decreased_physiological_sensi | 0.60680884 |
138 | MP0002060_abnormal_skin_morphology | 0.60060529 |
139 | MP0005334_abnormal_fat_pad | 0.59379415 |
140 | MP0005165_increased_susceptibility_to | 0.58950487 |
141 | MP0009697_abnormal_copulation | 0.58353011 |
142 | MP0006082_CNS_inflammation | 0.56606754 |
143 | MP0001243_abnormal_dermal_layer | 0.56466208 |
144 | MP0010368_abnormal_lymphatic_system | 0.55974585 |
145 | MP0003879_abnormal_hair_cell | 0.55959640 |
146 | MP0005395_other_phenotype | 0.55387223 |
147 | MP0000538_abnormal_urinary_bladder | 0.55382728 |
148 | MP0002269_muscular_atrophy | 0.54130768 |
149 | MP0004883_abnormal_blood_vessel | 0.53906748 |
150 | MP0000920_abnormal_myelination | 0.53723116 |
151 | MP0003172_abnormal_lysosome_physiology | 0.51091383 |
152 | MP0009765_abnormal_xenobiotic_induced | 0.50204257 |
153 | MP0000639_abnormal_adrenal_gland | 0.49991735 |
154 | MP0005166_decreased_susceptibility_to | 0.49246684 |
155 | MP0001533_abnormal_skeleton_physiology | 0.48633809 |
156 | MP0005448_abnormal_energy_balance | 0.46947246 |
157 | MP0005666_abnormal_adipose_tissue | 0.46714541 |
158 | MP0002909_abnormal_adrenal_gland | 0.44930165 |
159 | MP0009384_cardiac_valve_regurgitation | 0.44211586 |
160 | MP0000343_altered_response_to | 0.43708076 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.60332677 |
2 | Xanthomatosis (HP:0000991) | 5.12987795 |
3 | Deep venous thrombosis (HP:0002625) | 5.09493765 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.61395948 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.36439047 |
6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.36439047 |
7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.36439047 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.29525574 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.28568543 |
10 | Hypobetalipoproteinemia (HP:0003563) | 4.00855471 |
11 | Hyperglycinuria (HP:0003108) | 3.85675531 |
12 | Hyperammonemia (HP:0001987) | 3.80249505 |
13 | Abnormality of glycine metabolism (HP:0010895) | 3.72537170 |
14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.72537170 |
15 | Hyperglycinemia (HP:0002154) | 3.70340187 |
16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.67909954 |
17 | Complement deficiency (HP:0004431) | 3.66792140 |
18 | Ketosis (HP:0001946) | 3.64611708 |
19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58103207 |
20 | Prolonged partial thromboplastin time (HP:0003645) | 3.56189380 |
21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.56026348 |
22 | Gout (HP:0001997) | 3.40856266 |
23 | Hypolipoproteinemia (HP:0010981) | 3.38989723 |
24 | Abnormality of macrophages (HP:0004311) | 3.33790860 |
25 | Hypoalphalipoproteinemia (HP:0003233) | 3.31104906 |
26 | Recurrent abscess formation (HP:0002722) | 3.23921069 |
27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17848250 |
28 | Eczematoid dermatitis (HP:0000976) | 3.10489208 |
29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04067825 |
30 | Recurrent bacterial skin infections (HP:0005406) | 3.02041139 |
31 | Loss of speech (HP:0002371) | 3.00172329 |
32 | Petechiae (HP:0000967) | 2.98934882 |
33 | Ketoacidosis (HP:0001993) | 2.97980895 |
34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.96623073 |
35 | Obstructive lung disease (HP:0006536) | 2.92144569 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92144569 |
37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.91788094 |
38 | Cholecystitis (HP:0001082) | 2.89095225 |
39 | Abnormal gallbladder physiology (HP:0012438) | 2.89095225 |
40 | Increased cerebral lipofuscin (HP:0011813) | 2.85818079 |
41 | Purpura (HP:0000979) | 2.79975370 |
42 | Hypoglycemic coma (HP:0001325) | 2.75126677 |
43 | Fat malabsorption (HP:0002630) | 2.73738439 |
44 | Abnormality of complement system (HP:0005339) | 2.67581410 |
45 | Stomatitis (HP:0010280) | 2.64114736 |
46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63214056 |
47 | Dicarboxylic aciduria (HP:0003215) | 2.63214056 |
48 | Abnormality of purine metabolism (HP:0004352) | 2.61011378 |
49 | Abnormality of methionine metabolism (HP:0010901) | 2.60718434 |
50 | Neurofibrillary tangles (HP:0002185) | 2.60474777 |
51 | Prolonged neonatal jaundice (HP:0006579) | 2.60254368 |
52 | Upper motor neuron abnormality (HP:0002127) | 2.59139947 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58747370 |
54 | Epidermoid cyst (HP:0200040) | 2.56309331 |
55 | Abnormality of the common coagulation pathway (HP:0010990) | 2.55079440 |
56 | Lethargy (HP:0001254) | 2.54460729 |
57 | Distal lower limb muscle weakness (HP:0009053) | 2.49962186 |
58 | Systemic lupus erythematosus (HP:0002725) | 2.47952439 |
59 | Axonal loss (HP:0003447) | 2.47149905 |
60 | Abnormality of proline metabolism (HP:0010907) | 2.44560095 |
61 | Hydroxyprolinuria (HP:0003080) | 2.44560095 |
62 | Joint hemorrhage (HP:0005261) | 2.41850967 |
63 | Malnutrition (HP:0004395) | 2.40860066 |
64 | Irritability (HP:0000737) | 2.40633049 |
65 | Abnormality of serum amino acid levels (HP:0003112) | 2.39875761 |
66 | Vascular calcification (HP:0004934) | 2.36654178 |
67 | J-shaped sella turcica (HP:0002680) | 2.35956149 |
68 | Neonatal onset (HP:0003623) | 2.33158587 |
69 | Metabolic acidosis (HP:0001942) | 2.32737725 |
70 | Delayed CNS myelination (HP:0002188) | 2.32736529 |
71 | Cholelithiasis (HP:0001081) | 2.32589535 |
72 | Abnormal gallbladder morphology (HP:0012437) | 2.32200361 |
73 | Premature rupture of membranes (HP:0001788) | 2.31403844 |
74 | Amyloidosis (HP:0011034) | 2.31331318 |
75 | Mediastinal lymphadenopathy (HP:0100721) | 2.29004584 |
76 | Sensorimotor neuropathy (HP:0007141) | 2.28841103 |
77 | Hepatosplenomegaly (HP:0001433) | 2.28298970 |
78 | Myocardial infarction (HP:0001658) | 2.27722201 |
79 | Cardiovascular calcification (HP:0011915) | 2.27643917 |
80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.27318088 |
81 | Pustule (HP:0200039) | 2.26893335 |
82 | Hypercholesterolemia (HP:0003124) | 2.26513940 |
83 | Abnormality of the intrinsic pathway (HP:0010989) | 2.26048814 |
84 | Recurrent skin infections (HP:0001581) | 2.25557060 |
85 | Vomiting (HP:0002013) | 2.24797077 |
86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22788836 |
87 | Progressive neurologic deterioration (HP:0002344) | 2.20426611 |
88 | Cerebral inclusion bodies (HP:0100314) | 2.19869742 |
89 | Mitral stenosis (HP:0001718) | 2.18537781 |
90 | Abnormality of the Achilles tendon (HP:0005109) | 2.18153323 |
91 | Steatorrhea (HP:0002570) | 2.18095153 |
92 | Protrusio acetabuli (HP:0003179) | 2.18082696 |
93 | Myositis (HP:0100614) | 2.17392681 |
94 | Hypertriglyceridemia (HP:0002155) | 2.16878394 |
95 | Hypertensive crisis (HP:0100735) | 2.15617294 |
96 | Generalized aminoaciduria (HP:0002909) | 2.15443665 |
97 | Brushfield spots (HP:0001088) | 2.13459804 |
98 | Rhabdomyolysis (HP:0003201) | 2.12891448 |
99 | Hyperbilirubinemia (HP:0002904) | 2.12402896 |
100 | Hypokinesia (HP:0002375) | 2.11006580 |
101 | Increased purine levels (HP:0004368) | 2.11003751 |
102 | Hyperuricemia (HP:0002149) | 2.11003751 |
103 | Type I transferrin isoform profile (HP:0003642) | 2.09908816 |
104 | Cerebral edema (HP:0002181) | 2.09531379 |
105 | Skin nodule (HP:0200036) | 2.09529920 |
106 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.09297992 |
107 | Increased serum ferritin (HP:0003281) | 2.08925835 |
108 | Vacuolated lymphocytes (HP:0001922) | 2.07678428 |
109 | Dysostosis multiplex (HP:0000943) | 2.05760189 |
110 | Alkalosis (HP:0001948) | 2.03925388 |
111 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02147829 |
112 | Abnormal cartilage morphology (HP:0002763) | 1.99155163 |
113 | Beaking of vertebral bodies (HP:0004568) | 1.94641046 |
114 | Spastic paraparesis (HP:0002313) | 1.94018402 |
115 | Vertebral compression fractures (HP:0002953) | 1.92680565 |
116 | Polygenic inheritance (HP:0010982) | 1.92112481 |
117 | Urticaria (HP:0001025) | 1.91645105 |
118 | Rough bone trabeculation (HP:0100670) | 1.89679983 |
119 | Opisthotonus (HP:0002179) | 1.89171634 |
120 | Global brain atrophy (HP:0002283) | 1.87139867 |
121 | Peritonitis (HP:0002586) | 1.87006394 |
122 | Hepatic necrosis (HP:0002605) | 1.86945644 |
123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86530678 |
124 | Mucopolysacchariduria (HP:0008155) | 1.86530678 |
125 | Protuberant abdomen (HP:0001538) | 1.85846462 |
126 | Fatigue (HP:0012378) | 1.85282682 |
127 | Abnormality of the gallbladder (HP:0005264) | 1.85222591 |
128 | Proximal tubulopathy (HP:0000114) | 1.84543776 |
129 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.84179147 |
130 | Recurrent cutaneous fungal infections (HP:0011370) | 1.84179147 |
131 | Epistaxis (HP:0000421) | 1.83729474 |
132 | Thoracic kyphosis (HP:0002942) | 1.83326110 |
133 | Recurrent fungal infections (HP:0002841) | 1.82764803 |
134 | Hepatocellular carcinoma (HP:0001402) | 1.82497202 |
135 | Growth hormone excess (HP:0000845) | 1.80325402 |
136 | Interstitial pulmonary disease (HP:0006530) | 1.79525894 |
137 | Esophageal neoplasm (HP:0100751) | 1.79478777 |
138 | Neoplasm of head and neck (HP:0012288) | 1.79478777 |
139 | Glucose intolerance (HP:0000833) | 1.78780051 |
140 | Cerebral hemorrhage (HP:0001342) | 1.78517673 |
141 | Pancreatitis (HP:0001733) | 1.77862986 |
142 | Ileus (HP:0002595) | 1.77557567 |
143 | Late onset (HP:0003584) | 1.75899302 |
144 | Acute hepatic failure (HP:0006554) | 1.75835827 |
145 | Gastrointestinal stroma tumor (HP:0100723) | 1.75794845 |
146 | Epiphyseal stippling (HP:0010655) | 1.74984111 |
147 | Abnormal platelet function (HP:0011869) | 1.73476670 |
148 | Impaired platelet aggregation (HP:0003540) | 1.73476670 |
149 | Ragged-red muscle fibers (HP:0003200) | 1.73470044 |
150 | Gastrointestinal inflammation (HP:0004386) | 1.72401151 |
151 | Hepatocellular necrosis (HP:0001404) | 1.72382280 |
152 | Gingivitis (HP:0000230) | 1.72195421 |
153 | Joint stiffness (HP:0001387) | 1.70517920 |
154 | Abnormal protein glycosylation (HP:0012346) | 1.70510038 |
155 | Abnormal glycosylation (HP:0012345) | 1.70510038 |
156 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.70510038 |
157 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.70510038 |
158 | Asymmetric septal hypertrophy (HP:0001670) | 1.70260389 |
159 | Abnormality of the nasal mucosa (HP:0000433) | 1.69898920 |
160 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.69575447 |
161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.69575447 |
162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.69575447 |
163 | Meningitis (HP:0001287) | 1.69527862 |
164 | Spontaneous abortion (HP:0005268) | 1.69188714 |
165 | Colitis (HP:0002583) | 1.68676372 |
166 | Microretrognathia (HP:0000308) | 1.63597021 |
167 | Pulmonary infiltrates (HP:0002113) | 1.61050274 |
168 | Cervical subluxation (HP:0003308) | 1.60443721 |
169 | Inflammation of the large intestine (HP:0002037) | 1.59586343 |
170 | Erythema (HP:0010783) | 1.59437011 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.39778138 |
2 | BCKDK | 4.31458589 |
3 | TRIB3 | 3.19276720 |
4 | ARAF | 2.99552280 |
5 | SIK1 | 2.61931140 |
6 | IRAK3 | 2.58892123 |
7 | VRK2 | 2.40881376 |
8 | SMG1 | 2.34722594 |
9 | MAP4K1 | 2.27276445 |
10 | FGFR4 | 2.20511228 |
11 | PIM2 | 1.93215649 |
12 | NTRK1 | 1.70595815 |
13 | PRPF4B | 1.68932172 |
14 | DAPK2 | 1.67123802 |
15 | KSR2 | 1.62647928 |
16 | OXSR1 | 1.59094719 |
17 | TESK1 | 1.57658401 |
18 | CAMKK2 | 1.54398574 |
19 | FES | 1.47434261 |
20 | LIMK1 | 1.46700820 |
21 | MAP3K11 | 1.46694990 |
22 | MAPKAPK3 | 1.43977225 |
23 | TESK2 | 1.42415103 |
24 | TAOK2 | 1.41086392 |
25 | NME2 | 1.41033550 |
26 | PKN2 | 1.31799919 |
27 | CAMKK1 | 1.31230548 |
28 | WNK4 | 1.31196472 |
29 | IRAK4 | 1.29969157 |
30 | RIPK4 | 1.29933963 |
31 | GRK5 | 1.28913265 |
32 | KDR | 1.27329023 |
33 | LATS2 | 1.25269856 |
34 | PDK3 | 1.24393387 |
35 | PDK4 | 1.24393387 |
36 | PINK1 | 1.20803958 |
37 | MST1R | 1.17364177 |
38 | TBK1 | 1.14676650 |
39 | LMTK2 | 1.14526189 |
40 | TNK2 | 1.14307077 |
41 | MAP2K1 | 1.12949620 |
42 | PTK2B | 1.12248700 |
43 | MAP3K3 | 1.09508581 |
44 | LRRK2 | 1.07249478 |
45 | PDK2 | 1.07214894 |
46 | PAK4 | 1.04255694 |
47 | MET | 1.01718477 |
48 | DAPK3 | 1.01691932 |
49 | SCYL2 | 1.01114865 |
50 | EPHA2 | 1.00753186 |
51 | ABL2 | 0.99591233 |
52 | BTK | 0.97600229 |
53 | DDR2 | 0.97291190 |
54 | PRKD2 | 0.96960406 |
55 | MAP3K9 | 0.96360811 |
56 | STK16 | 0.95694589 |
57 | CSK | 0.95134392 |
58 | STK39 | 0.94754334 |
59 | PAK3 | 0.94340867 |
60 | MAP2K4 | 0.93209451 |
61 | PAK6 | 0.91874748 |
62 | TGFBR2 | 0.90149012 |
63 | IKBKB | 0.87713772 |
64 | EPHA4 | 0.87632166 |
65 | MOS | 0.86801294 |
66 | EPHB1 | 0.85727933 |
67 | ILK | 0.84744306 |
68 | ZAP70 | 0.84416710 |
69 | FER | 0.84322857 |
70 | MAP2K2 | 0.82667091 |
71 | INSRR | 0.82123233 |
72 | TYK2 | 0.81800452 |
73 | CDK19 | 0.81459297 |
74 | IKBKE | 0.80458483 |
75 | TAOK1 | 0.79285260 |
76 | CAMK2G | 0.79142518 |
77 | EIF2AK1 | 0.77907285 |
78 | BRAF | 0.77071774 |
79 | ITK | 0.76785813 |
80 | MYLK | 0.76134748 |
81 | PIK3CG | 0.74173188 |
82 | HCK | 0.74137367 |
83 | PDPK1 | 0.73969278 |
84 | GRK6 | 0.73769840 |
85 | BLK | 0.73556432 |
86 | PHKG2 | 0.73538220 |
87 | PHKG1 | 0.73538220 |
88 | MAPK12 | 0.73252055 |
89 | PTK2 | 0.71230986 |
90 | RIPK1 | 0.70931455 |
91 | TXK | 0.69819189 |
92 | MAPK15 | 0.69220693 |
93 | EIF2AK3 | 0.68269551 |
94 | PRKD3 | 0.67958114 |
95 | CSF1R | 0.67918411 |
96 | JAK3 | 0.67536800 |
97 | TEC | 0.67024997 |
98 | PAK1 | 0.65874843 |
99 | PDK1 | 0.65204357 |
100 | PDGFRA | 0.63841282 |
101 | SYK | 0.63824155 |
102 | PRKCZ | 0.63561142 |
103 | ERBB4 | 0.63288560 |
104 | RET | 0.63004259 |
105 | CDK8 | 0.62640253 |
106 | MAP3K1 | 0.62631340 |
107 | STK38L | 0.62058997 |
108 | MAP2K3 | 0.61971717 |
109 | LYN | 0.61025656 |
110 | MAP3K12 | 0.60946063 |
111 | MAP3K13 | 0.60578406 |
112 | SIK3 | 0.57995718 |
113 | LCK | 0.57204648 |
114 | PRKG2 | 0.56411776 |
115 | WNK3 | 0.56111065 |
116 | HIPK2 | 0.55697674 |
117 | KIT | 0.55642887 |
118 | MAP3K2 | 0.55274273 |
119 | EPHA3 | 0.54513031 |
120 | SGK223 | 0.53198238 |
121 | SGK494 | 0.53198238 |
122 | ICK | 0.53154684 |
123 | STK38 | 0.52095444 |
124 | NEK1 | 0.51293313 |
125 | MAPK11 | 0.51130878 |
126 | MARK3 | 0.50470009 |
127 | GRK7 | 0.49384152 |
128 | DAPK1 | 0.48602364 |
129 | RAF1 | 0.48590185 |
130 | PRKCG | 0.48051254 |
131 | CDK9 | 0.47816361 |
132 | CAMK1D | 0.46211980 |
133 | TAF1 | 0.44816577 |
134 | PRKCI | 0.44085671 |
135 | JAK2 | 0.42695240 |
136 | BMX | 0.42573686 |
137 | PRKACG | 0.42417163 |
138 | MAP2K6 | 0.42240273 |
139 | JAK1 | 0.42087483 |
140 | MAPK4 | 0.42002421 |
141 | STK10 | 0.41400503 |
142 | CAMK2D | 0.40563551 |
143 | MINK1 | 0.39171572 |
144 | MAPKAPK2 | 0.38528085 |
145 | TTN | 0.38166784 |
146 | PTK6 | 0.38080390 |
147 | CAMK2B | 0.37863923 |
148 | MAP3K8 | 0.37229889 |
149 | NEK9 | 0.35546538 |
150 | PRKD1 | 0.35017020 |
151 | CDC42BPA | 0.33259937 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.72813319 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95640213 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92988372 |
4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70564036 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.66090022 |
6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62365912 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53521815 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51852935 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50093677 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.28210556 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15595468 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13638862 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13133288 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.11259572 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.06337157 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06121381 |
17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.04404933 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98444055 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86237146 |
20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83855087 |
21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.80735785 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78283159 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78214936 |
24 | Allograft rejection_Homo sapiens_hsa05330 | 1.72706277 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71857741 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71039598 |
27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70697380 |
28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.68558735 |
29 | Proteasome_Homo sapiens_hsa03050 | 1.66970699 |
30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.66919614 |
31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65928956 |
32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59680552 |
33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55568139 |
34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55388630 |
35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54387621 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48893196 |
37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47027330 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.46198403 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44681117 |
40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41872790 |
41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41761343 |
42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40139170 |
43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39204642 |
44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.39110231 |
45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38748849 |
46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38292818 |
47 | Asthma_Homo sapiens_hsa05310 | 1.37642837 |
48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36237124 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35252109 |
50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34195468 |
51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32591277 |
52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31984426 |
53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31011665 |
54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28858449 |
55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26885204 |
56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25688006 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25020179 |
58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22544161 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21477191 |
60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19748783 |
61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18769703 |
62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18231448 |
63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15810982 |
64 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15281239 |
65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14720406 |
66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12601282 |
67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12116003 |
68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09721890 |
69 | Pertussis_Homo sapiens_hsa05133 | 1.07716661 |
70 | Tuberculosis_Homo sapiens_hsa05152 | 1.04590943 |
71 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03960648 |
72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02409362 |
73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01446954 |
74 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01254485 |
75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99651313 |
76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97417604 |
77 | Base excision repair_Homo sapiens_hsa03410 | 0.96366576 |
78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96146838 |
79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95321819 |
80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94308720 |
81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93449573 |
82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90945328 |
83 | Ribosome_Homo sapiens_hsa03010 | 0.90536948 |
84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89941875 |
85 | Salmonella infection_Homo sapiens_hsa05132 | 0.88062138 |
86 | Shigellosis_Homo sapiens_hsa05131 | 0.88048265 |
87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86308753 |
88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85777726 |
89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80548142 |
90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79238950 |
91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79093361 |
92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78944901 |
93 | ABC transporters_Homo sapiens_hsa02010 | 0.78552154 |
94 | Malaria_Homo sapiens_hsa05144 | 0.78114077 |
95 | Measles_Homo sapiens_hsa05162 | 0.73195044 |
96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72845683 |
97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72026309 |
98 | Lysosome_Homo sapiens_hsa04142 | 0.70937685 |
99 | Influenza A_Homo sapiens_hsa05164 | 0.70130774 |
100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69992047 |
101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69120679 |
102 | Apoptosis_Homo sapiens_hsa04210 | 0.68819730 |
103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66681977 |
104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65126903 |
105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64017678 |
106 | Legionellosis_Homo sapiens_hsa05134 | 0.63501776 |
107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60023644 |
108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58555349 |
109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58346675 |
110 | DNA replication_Homo sapiens_hsa03030 | 0.55476897 |
111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54491128 |
112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51286253 |
113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49835974 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49706572 |
115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49423890 |
116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49233905 |
117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48976808 |
118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47790992 |
119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47601787 |
120 | Prion diseases_Homo sapiens_hsa05020 | 0.43209891 |
121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41721398 |
122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41600241 |
123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40659328 |
124 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40628355 |
125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40311954 |
126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36445373 |
127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34438711 |
128 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29851930 |
129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29387133 |
130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27535438 |
131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.27158691 |
132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25641628 |
133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25367083 |
134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.21381310 |
135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.20740035 |
136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19811366 |
137 | Mineral absorption_Homo sapiens_hsa04978 | 0.15340176 |
138 | Insulin resistance_Homo sapiens_hsa04931 | 0.13508708 |
139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12874184 |
140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12316784 |
141 | Phagosome_Homo sapiens_hsa04145 | 0.09068063 |
142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08573557 |
143 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07473759 |
144 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06577077 |
145 | Lysine degradation_Homo sapiens_hsa00310 | 0.05153518 |
146 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.04565139 |
147 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.03389070 |